3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
1
Interventions
Mitomycin
9
Gemcitabine
5
apaziquone
3
Docetaxel
2
valrubicin
1
pembrolizumab
1
linrodostat
1
erdafitinib
1
enzalutamide
1
avelumab
1
VB4-845
1
Standard of Care
1
Nivolumab
1
Neoadjuvant Therapy
1
Hyaluronic Acid
1
DDMS
1
BCG Vaccine
1
Administration, Intravesical
1
ALT-801
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Non-Muscle Invasive Bladder Neoplasms
×
VB4-845
×
Clear all
NCT02449239
2023-07-24
VISTA
Sesen Bio, Inc.
Phase 3
Completed
133 enrolled
18 charts